Bezuclastinib
Star0
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Bezuclastinib
- DrugBank Accession Number
- DB18041
- Background
Not Available
- Type
- Small Molecule
- Groups
- Investigational
- Structure
- Weight
- Average: 331.379
Monoisotopic: 331.143310187 - Chemical Formula
- C19H17N5O
- Synonyms
- 3,4-dimethyl-n-(2-phenyl-1h-pyrrolo(2,3-b)pyridin-5-yl)-1h-pyrazole-5-carboxamide
- 3,4-dimethyl-N-(2-phenyl-1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazole-5- carboxamide
- External IDs
- CGT9486
- PLX-9486
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Not Available
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 2ROQ545LAG
- CAS number
- 1616385-51-3
- InChI Key
- NVSHVYGIYPBTEZ-UHFFFAOYSA-N
- InChI
- InChI=1S/C19H17N5O/c1-11-12(2)23-24-17(11)19(25)21-15-8-14-9-16(22-18(14)20-10-15)13-6-4-3-5-7-13/h3-10H,1-2H3,(H,20,22)(H,21,25)(H,23,24)
- IUPAC Name
- 4,5-dimethyl-N-{2-phenyl-1H-pyrrolo[2,3-b]pyridin-5-yl}-1H-pyrazole-3-carboxamide
- SMILES
- CC1=C(C)C(=NN1)C(=O)NC1=CN=C2NC(=CC2=C1)C1=CC=CC=C1
References
- General References
- Not Available
- External Links
- ChemSpider
- 115007996
- BindingDB
- 392363
- ChEMBL
- CHEMBL5095229
- PDBe Ligand
- WEJ
- PDB Entries
- 7khk
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 3 Recruiting Treatment Advanced Gastrointestinal Stromal Tumor (GIST) / Metastatic Cancer 1 2 Not Yet Recruiting Treatment Gastrointestinal Stromal Tumor (GIST) 1 2 Recruiting Treatment Advanced Systemic Mastocytosis (AdvSM) / Aggressive Systemic Mastocytosis / Mast Cell Leukemia (MCL) / SM With an Associated Hematologic Neoplasm (SM-AHN) 1 2 Recruiting Treatment Mastocytosis, Indolent / SSM / Systemic Mastocytosis / Urticaria Pigmentosa 1 1, 2 Completed Treatment Gastrointestinal Stromal Tumor (GIST) 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source logP 3.28 Chemaxon pKa (Strongest Acidic) 12.85 Chemaxon pKa (Strongest Basic) 2.55 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 3 Chemaxon Hydrogen Donor Count 3 Chemaxon Polar Surface Area 86.46 Å2 Chemaxon Rotatable Bond Count 3 Chemaxon Refractivity 98.99 m3·mol-1 Chemaxon Polarizability 37.36 Å3 Chemaxon Number of Rings 4 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Not Available
- Chromatographic Properties
Collision Cross Sections (CCS)
Not Available
Drug created at September 08, 2023 18:49 / Updated at September 12, 2023 18:33